About Spectral MD
AI
Spectral MD develops technology using predictive analytics and AI algorithms to help clinicians make more accurate and faster treatment decisions. There are no diagnostic imaging devices that provide clinicians with an objective and immediate assessment of a wound’s healing potential.
Spectral MD’s DeepView® Technology provides an informed solution for clinicians and allows for a clear picture of the wound to be established prior to treatment or other interventions.
DeepView® is a portable imaging platform that allows for immediate wound healing assessment and provides clinicians with physiological information that is not visible to the human eye.
Spectral MD owns its cloud-based data pipeline, from patient data collection to an output that is meaningful to the clinician. This information can be used by physicians to guide therapeutic procedures for the patient.
Leadership Team
Chief Executive Officer, Co-Founder
Wensheng Fan is a Co-Founder and the first employee of Spectral MD. Over the past 11 years he has served as CTO and COO, before becoming the CEO of Spectral MD. He is an executive, entrepreneur, and innovator with over 20 years of experience in natural speech recognition and imaging systems. Mr. Fan held various leadership roles in strategy, engineering, and operations with Sensata Technologies and Philips. He also has a long history of experience in business development and cross-functional team leadership, being a founder and/or early core member of multiple successful start-up companies. Under his leadership, Spectral MD’s DeepView® was granted FDA Breakthrough Device designation and is well on its way to disrupting the field of healthcare and medical technology.
Mr. Fan received his B.S.E.E. degree from Tsinghua University in Beijing, China and M.S.E.E. degree from Northeastern University in Boston.
Chief Financial Officer
Mr. Windler brings more than 20 years of Finance and Operations experience and is recognized as a hands-on, forward-thinking executive and business strategist who leverages extensive financial, operations and sales experience to fuel revenue growth, enhance profitability and seamlessly execute organizational turnarounds and transformations. Prior to joining Spectral MD, Mr. Windler served as Senior Finance Leader and Business Finance Transformation Leader at 3M. Prior to its acquisition, Mr. Windler also served as Vice President of Finance for Americas at KCI, an Acelity company, for several years and supported the preparation and execution of its exit event. Additionally, Mr. Windler has several years of executive Finance and Operations experience in the U.S. and Germany in the Medical Imaging Equipment, Cardiac Rhythm Management and Vascular Intervention space where he worked for Siemens Health Care and BIOTRONIK.
Mr. Windler holds an MBA, General Management from The Berlin School of Economics & Law & Anglia Ruskin University in Cambrige, U.K. and a BA, Business Administration, Banking Management, Finance & Investments from The Berlin School of Economics and Law.
Chief Scientist
Jeffrey Thatcher, PhD serves as the Chief Scientist at Spectral MD. He currently oversees technology and applications research for medical imaging systems. He is a former Howard Hughes Medical Institute (HHMI) undergraduate research fellow, has served as PI on three National Science Foundation (NSF) grants, and is currently the PI of an Health and Human Services Biomedical Advanced Research and Development Authority (HHS/BARDA) government contract to develop an imaging device to assist with burn care. In 2015, Dr. Thatcher presented a summary of Spectral MD's preclinical burn wound imaging studies at the American Burn Association meeting, where he won the Burke-Yannas Award for the best biomedical engineering paper presented at the conference.
Dr. Thatcher received a B.S. in molecular biology from Texas Tech University and Ph.D. in biomedical engineering from University of Texas Southwestern Medical Center.
Kevin Plant leads Software Engineering at Spectral MD. He currently directs the Application Software and Deep Learning Data Science teams, and drives the medical device product development process. He has spent his career transforming medical research into released medical devices, and specializes in medical device Systems and Software development. Before Spectral MD, he worked in neuro and cardiac implantable research and development with St. Jude Medical and Abbott. He also worked in research at Houston Methodist, and his project traveled to the International Space Station (ISS) aboard the SpaceX Dragon 9 spacecraft to investigate constrained diffusion in microgravity.
Kevin received a B.S. in Biomedical Engineering from the University of Texas at Austin.
Vice President, Software
Vice President, Production and System Engineering
Louis Percoco is a seasoned engineering leader who brings more than 31 years of experience to the field of Research, Development, and Production. Louis has spent his career developing and manufacturing Electronics, Software, and Hardware benefiting the Medical Device Industry. Recognized as a thought leader in the field of software and electronic controlled medical devices, Louis has led R&D and Production teams in Cardiology, Orthopedic and Spine disciplines. The result of this R&D has been acknowledged with the award of:
-
FDA 510(k) Clearance – “DeepView Medical Imaging Device” [K124049] for DeepView Gen2
-
Full FDA 21CFR 820 Compliance QSR System and Process for DeepView, and GMP Production Line
Vice President, Operations, Government and Regulatory Affairs
Maria Cadic, Ph.D. serves as Vice President of Project Management and Operations at Spectral MD. She is a PMP certified Project Manager with over 13 years of experience in various industries. Prior to joining Spectral MD in 2017, Dr. Cadic spent most of her career managing the execution of Government Contracts in Aviation with a focus on Federal Reporting and Earned Value Management. She also has extensive experience with Technical Hardware and Software Development Projects in the railroad industry. At Spectral MD, Dr. Cadic currently oversees the execution of a Health and Human Services Biomedical Advanced Research and Development Authority (HHS/BARDA) government contract to develop an imaging device to assist with burn care. She also oversees the company Business Operations.
Dr. Cadic received her B.S. in Mathematics and Sciences from the University of Bordeaux, France, her M. Eng. In Electrical Engineering from the Institut Des Sciences et de la Matiere in Caen, France, and her Ph.D. in Applied Mathematics from Twente University in Enschede, Netherlands.
Vice President, Clinical Affairs
Mary Regan, Ph.D. serves as VP Clinical Affairs at Spectral MD where she oversees all clinical trials and supports the commercial business operations. Dr. Regan brings over 30 years of clinical experience in wound technology assessment, development, research, and innovation with major industry leaders. Widely renowned in national and international forums as an industry thought leader in wound care, Dr. Regan’s career has been dedicated to the care of patients with chronic wounds and burns, the education of clinicians globally to improve prevention and management of chronic wounds and clinical research to improve outcomes for all patients with wounds. Dr. Regan has held board positions in the American Association of Wound Care Specialists and National Wound Healing Society.
Dr. Regan received her Masters/B.S Degree in Registered Nursing, Nursing Administration, Nursing Research, and Clinical Nursing from SUNY Upstate Medical University and PH.D. in Nursing Science from the University of Miami.
Head of UK/EU Clinical Research
So-Jin Holohan, Ph.D. leads the UK/EU clinical research at Spectral MD and has extensive R&D experience gained from academia, biotech and healthcare sector where she has dedicated eleven years to clinical research in different disease states and therapies. As a Positron Emission Tomography Mathematical Modeller and Drug R&D Methodologist at GE Healthcare, she gained much commercial experience as a point of contact between the company and clients in a multidisciplinary medical device environment. With background in natural sciences, life sciences, and clinical research, she has held roles which depended on knowledge transfer aimed at bridging the gaps between different disciplines. Away from the academic roles, Dr Holohan has supported, in commercial capacity, biotech, pharma and management consulting firms, and prior to joining Spectral MD Holdings, Ltd. she acted as Independent Medical Device Expert for listing Spectral MD at the London Stock Exchange AIM.
Dr Holohan received B.Sc. in Physics from Imperial College London and Ph.D. in Nuclear Medicine from King’s College London.
Chief Medical Consultant
In the Chief Medical Consultant role, Dr. Carter will be guiding Spectral MD’s clinical direction and ensuring that the company’s technology has a meaningful clinical impact for patients and physicians. Dr. Carter has been practicing burn/trauma medicine for over 12 years and currently serves as the Medical Director for the University Medical Center Burn Center in New Orleans, LA, and on faculty at Louisiana State University Health Sciences Center. “Spectral MD’s DeepView technology has the potential to change the course of treatment for thousands of patients suffering from wounds. I look forward to contributing my professional insight and experience,” stated Dr. Carter.
Dr. Carter earned his medical degree from East Tennessee State University in 2005 with honors and practiced general surgery and surgery critical care before specializing in burn treatment. He completed his burn/trauma fellowship at University of North Carolina, Chapel Hill and is board-certified by the American Board of Surgery in Surgery and Surgical Critical Care.
Spectral MD
Dallas, Texas, United States
Our headquarters are located in the heart of Uptown in Dallas. A tad north of downtown Dallas and connected by Klyde Warren Park, Uptown is a dynamic district known as a popular destination for residents and visitors alike.
Spectral MD is located within the Chateau Plaza office building on McKinney Avenue, within walking distance to best-in-class restaurants, residences, and retail. We are only five minutes from Dallas Love Field and twenty-five minutes from Dallas/Fort Worth International Airport. Our location also has easy ingress/egress to major freeways: I-35, I-45, US-75, and Dallas North Tollway, with onsite parking.